S119: PRELIMINARY RESULTS OF A PHASE 1 STUDY IN HEALTHY SUBJECTS ADMINISTERED INCLACUMAB, A FULLY HUMAN IGG4 ANTI-P-SELECTIN MONOCLONAL ANTIBODY IN DEVELOPMENT FOR TREATMENT OF SIC...

por Mayer, C, Cooper, D, Redfern, A, Geng, X, Shi, J, Zutphen-van Geffen, M, Kuan, I, Koek, K, Kastrissios, H, Patel, K, Davis, M, Yue, P
Publicado 2022